These GO terms are enriched significantly among genes that interact with Cisplatin or its descendants. We show only terms with a corrected p-value <0.01.
| Ontology | Highest GO Level | GO Term | P-value | Corrected P-value | Annotated Genes | Genome Frequency | |
|---|---|---|---|---|---|---|---|
| 1. | BP | 2 | anatomical structure development | 0 | 0 | 2,230 | 5225/42469 genes: 12.30% |
| 2. | BP | 2 | anatomical structure morphogenesis | 0 | 0 | 1,111 | 2303/42469 genes: 5.42% |
| 3. | BP | 3 | animal organ development | 0 | 0 | 1,383 | 3169/42469 genes: 7.46% |
| 4. | BP | 5 | apoptotic process | 0 | 0 | 957 | 1751/42469 genes: 4.12% |
| 5. | BP | 4 | aromatic compound biosynthetic process | 0 | 0 | 1,655 | 4215/42469 genes: 9.92% |
| 6. | BP | 1 | biological regulation | 0 | 0 | 4,138 | 10626/42469 genes: 25.02% |
| 7. | BP | 2 | biosynthetic process | 0 | 0 | 2,410 | 6121/42469 genes: 14.41% |
| 8. | BP | 2 | cell communication | 0 | 0 | 2,374 | 5567/42469 genes: 13.11% |
| 9. | BP | 3 | cell death | 0 | 0 | 1,054 | 1983/42469 genes: 4.67% |
| 10. | BP | 4 | cell differentiation | 0 | 0 | 1,578 | 3622/42469 genes: 8.53% |
| 11. | BP | 3 | cell surface receptor signaling pathway | 0 | 0 | 1,174 | 2520/42469 genes: 5.93% |
| 12. | BP | 3 | cellular aromatic compound metabolic process | 0 | 0 | 2,229 | 5691/42469 genes: 13.40% |
| 13. | BP | 3 | cellular biosynthetic process | 0 | 0 | 2,332 | 5962/42469 genes: 14.04% |
| 14. | BP | 2 | cellular component organization | 0 | 0 | 2,341 | 5499/42469 genes: 12.95% |
| 15. | BP | 1 | cellular component organization or biogenesis | 0 | 0 | 2,387 | 5680/42469 genes: 13.37% |
| 16. | BP | 3 | cellular developmental process | 0 | 0 | 1,651 | 3776/42469 genes: 8.89% |
| 17. | BP | 4 | cellular macromolecule biosynthetic process | 0 | 0 | 1,864 | 4876/42469 genes: 11.48% |
| 18. | BP | 3 | cellular macromolecule metabolic process | 0 | 0 | 3,073 | 7954/42469 genes: 18.73% |
| 19. | BP | 2 | cellular metabolic process | 0 | 0 | 3,879 | 9878/42469 genes: 23.26% |
| 20. | BP | 4 | cellular nitrogen compound biosynthetic process | 0 | 0 | 1,828 | 4770/42469 genes: 11.23% |
| 21. | BP | 3 | cellular nitrogen compound metabolic process | 0 | 0 | 2,381 | 6139/42469 genes: 14.46% |
| 22. | BP | 1 | cellular process | 0 | 0 | 5,323 | 14357/42469 genes: 33.81% |
| 23. | BP | 4 | cellular protein metabolic process | 0 | 0 | 1,937 | 4642/42469 genes: 10.93% |
| 24. | BP | 5 | cellular protein modification process | 0 | 0 | 1,593 | 3705/42469 genes: 8.72% |
| 25. | BP | 3 | cellular response to chemical stimulus | 0 | 0 | 1,328 | 2604/42469 genes: 6.13% |
| 26. | BP | 4 | cellular response to organic substance | 0 | 0 | 1,073 | 2119/42469 genes: 4.99% |
| 27. | BP | 2 | cellular response to stimulus | 0 | 0 | 2,720 | 6296/42469 genes: 14.82% |
| 28. | BP | 1 | developmental process | 0 | 0 | 2,377 | 5592/42469 genes: 13.17% |
| 29. | BP | 2 | establishment of localization | 0 | 0 | 1,952 | 4872/42469 genes: 11.47% |
| 30. | BP | 4 | gene expression | 0 | 0 | 1,920 | 5127/42469 genes: 12.07% |
| 31. | BP | 4 | heterocycle biosynthetic process | 0 | 0 | 1,658 | 4210/42469 genes: 9.91% |
| 32. | BP | 3 | heterocycle metabolic process | 0 | 0 | 2,213 | 5655/42469 genes: 13.32% |
| 33. | BP | 3 | intracellular signal transduction | 0 | 0 | 1,198 | 2390/42469 genes: 5.63% |
| 34. | BP | 1 | localization | 0 | 0 | 2,387 | 5860/42469 genes: 13.80% |
| 35. | BP | 4 | macromolecule biosynthetic process | 0 | 0 | 1,927 | 5017/42469 genes: 11.81% |
| 36. | BP | 3 | macromolecule metabolic process | 0 | 0 | 3,301 | 8657/42469 genes: 20.38% |
| 37. | BP | 4 | macromolecule modification | 0 | 0 | 1,676 | 3933/42469 genes: 9.26% |
| 38. | BP | 1 | metabolic process | 0 | 0 | 4,147 | 10734/42469 genes: 25.27% |
| 39. | BP | 1 | multicellular organismal process | 0 | 0 | 2,673 | 6936/42469 genes: 16.33% |
| 40. | BP | 3 | multicellular organism development | 0 | 0 | 2,048 | 4811/42469 genes: 11.33% |
| 41. | BP | 1 | negative regulation of biological process | 0 | 0 | 2,063 | 4611/42469 genes: 10.86% |
| 42. | BP | 2 | negative regulation of cellular process | 0 | 0 | 1,887 | 4151/42469 genes: 9.77% |
| 43. | BP | 2 | nitrogen compound metabolic process | 0 | 0 | 3,596 | 9342/42469 genes: 22.00% |
| 44. | BP | 4 | nucleic acid metabolic process | 0 | 0 | 1,898 | 4906/42469 genes: 11.55% |
| 45. | BP | 4 | nucleobase-containing compound biosynthetic process | 0 | 0 | 1,624 | 4149/42469 genes: 9.77% |
| 46. | BP | 3 | nucleobase-containing compound metabolic process | 0 | 0 | 2,136 | 5491/42469 genes: 12.93% |
| 47. | BP | 4 | organic cyclic compound biosynthetic process | 0 | 0 | 1,729 | 4354/42469 genes: 10.25% |
| 48. | BP | 3 | organic cyclic compound metabolic process | 0 | 0 | 2,332 | 5902/42469 genes: 13.90% |
| 49. | BP | 3 | organic substance biosynthetic process | 0 | 0 | 2,383 | 6055/42469 genes: 14.26% |
| 50. | BP | 2 | organic substance metabolic process | 0 | 0 | 3,964 | 10231/42469 genes: 24.09% |